ACD PHARMACEUTICALS AS: årsregnskap 2014 vs 2013
Shrank 24% on revenue
approved 2015-06-30; registry 2015-09-28; journal 2015 884883
Summary
What changed
Comparing Årsregnskap 2014 with 2013 for ACD PHARMACEUTICALS AS. Revenue 8.31m NOK → 6.32m NOK (-24.0%). Equity 3.95m NOK → 5.14m NOK.
On the constructive side: equity strengthened. Pressures included: revenue fell; cash fell; payroll up without matching revenue.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 3.95m NOK → 5.14m NOK (equity ratio 37.0% → 44.0%). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 8.31m NOK to 6.32m NOK (-24.0% YoY). Calculated
-
↓
Cash fell
Bank deposits 175.8k NOK → 158.0k NOK (-10.1% YoY). Calculated
-
↓
Payroll up without matching revenue
Salary cost 2.66m NOK → 4.02m NOK (32% → 64% of revenue). Calculated
-
↓
COGS moved
COGS / varekostnad 832.2k NOK → 859.9k NOK (+3.3% YoY). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 300.0k NOK → 170.9k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 10.0k NOK → 45.0k NOK. Reported fact